All Venous thromboembolism articles
-
VideoModern management of stroke prevention in non-valvular atrial fibrillation
These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View ELIQUIS (apixaban) prescribing and adverse event reporting information
432-GB-2100689 | Date of preparation: August 2021 -
News
Blood clot risks ‘lower with COVID vaccines than from infection’
A study has found the risk of haematological and vascular adverse events following a first dose of two COVID vaccines was significantly lower than from infection with SARS-CoV-2
-
Video
The holistic management of patients requiring anticoagulation
This video has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View Xarelto▼(rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-1924 January 2021 -
News
NICE publishes new COVID-19 guideline on reducing VTE
NICE has published a new guideline on pharmacological venous thromboembolism prophylaxis for patients being treated for COVID-19 pneumonia, which includes patients receiving treatment in hospital or in a community setting
-
Working party guideline/algorithm
Consensus guideline on the holistic management of patients requiring anticoagulation
This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of an educational grant from Bayer plc.
-
NICE guideline
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
This useful summary covers diagnosis and initial management, outpatient treatment for low-risk pulmonary embolism, anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism, and information and support for people having anticoagulation treatment
